ELAN ALERT: Rigrodsky Law, P.A. Is Investigating Elanco Animal Health Incorporated On Behalf of Shareholders
Tuesday, 22 October 2024 07:00 AM
Class Action
WILMINGTON, DE / ACCESS Newswire / October 22, 2024 / Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Elanco Animal Health Incorporated ("Elanco" or the "Company") (NYSE:ELAN) on behalf of stockholders.
If you purchased or otherwise acquired Elanco shares on or before November 7, 2023 and want to learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-elanco-animal-health-incorporated. You may also contact Leah Wihtelin cost free at (516) 693-8926 or by email at [email protected].
About the Investigation:
The investigation concerns whether Elanco and certain of its directors and/or officers issued materially misleading information and/or failed to disclose material information to the investing public. Specifically, the investigation concerns whether Elanco and certain of its directors and/or officers failed to disclose to shareholders, among other things, that: (i) one of the Company's proprietary products, Zenrelia, was less safe than the Company claimed; (ii) Elanco was unlikely to meet its previously-announced timeline for U.S. approval and commercial launch of Zenrelia and another one of the Company's products, Credelio Quattro; and (iii) as a result, the Company's business and/or financial prospects were overstated.
About Rigrodsky Law:
Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.
Attorney advertising. Prior results do not guarantee a similar outcome.
Contact:
Rigrodsky Law, P.A.
Seth D. Rigrodsky, Esq.
Gina M. Serra, Esq.
Call or Text: (302) 295-5310
Email: [email protected]
SOURCE: Rigrodsky Law, P.A.
